| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.14 | 0.08 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |